Effect of mesenchymal stem cell treatment on retinopathy of prematurity in patients with bronchopulmonary dysplasia: experience of a tertiary center
Abstract
BACKGROUND: Retinopathy of prematurity (ROP) and bronchopulmonary dysplasia (BPD) share overlapping mechanisms involving oxidative stress, inflammation, and aberrant angiogenesis. Mesenchymal stem cell (MSC) therapy has shown promise in the treatment of BPD through paracrine modulation and anti-inflammatory effects, but its influence on retinal vascular development remains uncertain. CASE PRESENTATION: This retrospective case series included five extremely low birth weight (ELBW) infants (
Fields of Study & Subjects
Neonatal Respiratory Health Research
Retinopathy of Prematurity Studies
Mesenchymal stem cell research
Publication details
- Journal / source
- The Turkish Journal of Pediatrics
- Publisher
- Hacettepe University Institute of Child Health
- Volume
- 68
- Issue
- 2
- Pages
- 345–351
- Publication date
- 30 April 2026
- Language
- EN